PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE (NSC-740)

被引：0
|
作者：
STOLLER, RG
JACOBS, SA
DRAKE, JC
LUTZ, RJ
CHABNER, BA
机构：
[1] NIH, DIV RES SERV, BIOMED ENGN & INSTR BRANCH, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT,LAB CHEM PHARMACOL,BLDG 10, RM6N119, BETHESDA, MD 20014 USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT | 1975年 / 6卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：19 / 24
页数：6
相关论文
共 50 条
  • [31] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE (NSC-26271), CYTOSINE-ARABINOSIDE (NSC-63878), AND METHOTREXATE (NSC-740) IN ADVANCED SOLID TUMORS
    ODUJINRIN, OO
    DECONTI, RC
    BERTINO, JR
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1091 - 1096
  • [32] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE TREATMENT IN CHILDREN
    BRATLID, D
    MOE, PJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) : 143 - 147
  • [33] EVALUATION OF DAUNORUBICIN (NSC-82151) AND METHOTREXATE (NSC-740) IN COMBINATION AS A REMISSION MAINTENANCE REGIMEN IN TREATMENT OF ACUTE-LEUKEMIA
    HUMPHREY, GB
    FERNBACH, DJ
    RAZEK, AA
    STUCKEY, WJ
    KOMP, D
    GEORGE, S
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 395 - 399
  • [34] CONTROLLED EVALUATION OF COMBINATION OF ADRIAMYCIN (NSC-123127), VINCRISTINE (NSC-67574), AND METHOTREXATE (NSC-740) IN PATIENTS WITH DISSEMINATED BREAST-CANCER
    EAGAN, RT
    AHMANN, DL
    EDMONSON, JH
    HAHN, RG
    BISEL, HF
    CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 339 - 342
  • [35] COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE (NSC-26271),METHOTREXATE (NSC-740), AND PREDNISOLONE (NSC-9900) (CMP PROTOCOL), FOR METASTATIC BREAST-CANCER
    UMSAWASDI, T
    NILPRABHASSORN, P
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1978, 61 (03): : 158 - 161
  • [36] CLINICAL-PHARMACOLOGY OF METHOTREXATE - PHARMACOKINETICS OF HIGH-DOSE ORAL METHOTREXATE
    MATSUOKA, H
    SASAKI, K
    FUJIMOTO, T
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 404 - 404
  • [37] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE
    ISACOFF, WH
    MORRISON, PF
    AROESTY, J
    WILLIS, KL
    BLOCK, JB
    LINCOLN, TL
    CANCER TREATMENT REPORTS, 1977, 61 (09): : 1665 - 1674
  • [38] EVALUATION OF COMBINATION OF HEXAMETHYLMELAMINE (NSC-13875) AND METHTREXATE (NSC-740) IN CARCINOMA OF LUNG
    WEISS, AJ
    WILSON, WL
    CANCER CHEMOTHERAPY REPORTS PART 1, 1971, 55 (03): : 299 - &
  • [39] PRECLINICAL PHARMACOKINETICS OF HIGH-DOSE ANAXIRONE (TGU NSC-332488)
    SCHILCHER, RB
    BEELEN, DW
    SCHMIDTWEIMAR, AC
    SCHAEFER, UW
    SCHMITTGRAFF, A
    NOWROUSIAN, MR
    HENGST, B
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 486 - 486
  • [40] COMBINATION CHEMOTHERAPY WITH METHOTREXATE (NSC-740), ADRIAMYCIN (NSC-123127), CYCLOPHOSPHAMIDE (NSC-26271), AND 5-FLUOROURACIL (NSC-19893) FOR ADULT SOLID TUMORS
    STEPHENS, RL
    HOOGSTRATEN, B
    CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (06): : 943 - 945
12345